Firstly, our research only focused on the expression of gankyrin in triple-negative breast cancer, thus it is essential to determine if it is also expressed in other cell lines or tumors and to assess if it has a similar inhibitory effect on tumor ferroptosis. The gene discussed is PSMD10; the disease is triple-negative breast carcinoma.